TL1A: A mediator of gut inflammation
- 30 May 2006
- journal article
- editorial
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 103 (22), 8303-8304
- https://doi.org/10.1073/pnas.0602655103
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Role of TL1A and its receptor DR3 in two models of chronic murine ileitisProceedings of the National Academy of Sciences of the United States of America, 2006
- Involvement of TL1A and DR3 in induction of pro-inflammatory cytokines and matrix metalloproteinase-9 in atherogenesisCytokine, 2005
- Anti–Interleukin-12 Antibody for Active Crohn's DiseaseThe New England Journal of Medicine, 2004
- Potential role for TL1A, the new TNF-family member and potent costimulator of IFN-γ, in mucosal inflammationClinical Immunology, 2004
- TL1A Synergizes with IL-12 and IL-18 to Enhance IFN-γ Production in Human T Cells and NK CellsThe Journal of Immunology, 2004
- Expression, Localization, and Functional Activity of TL1A, a Novel Th1-Polarizing Cytokine in Inflammatory Bowel DiseaseThe Journal of Immunology, 2003
- TL1A-induced NF-κB Activation and c-IAP2 Production Prevent DR3-mediated Apoptosis in TF-1 CellsOnline Journal of Public Health Informatics, 2003
- Natalizumab for Active Crohn's DiseaseThe New England Journal of Medicine, 2003
- TL1A Is a TNF-like Ligand for DR3 and TR6/DcR3 and Functions as a T Cell CostimulatorImmunity, 2002
- Treatment of Murine Colitis by Lactococcus lactis Secreting Interleukin-10Science, 2000